Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|August 2, 2021
- Pharmaceutical Technology, August 2021 Issue
- Volume 45
- Issue 8
Dual-Shaft Mixer with High Shear Rotor/Stator from ROSS
Author(s)Pharmaceutical Technology Editors
ROSS Dual-Shaft Mixer is designed to place intense shearing and homogenization at the forefront.
ROSS incorporated a high shear rotor/ stator into its Dual-Shaft Mixer to meet more intense shearing and homogenization requirements.
Rather than including a typical high-speed disperser blade, the mixer comes equipped with a rotor and slotted stator mixing head, also called a homogenizer, for more advanced deagglomeration and emulsification capabilities. The product also features a two-wing anchor that promotes bulk flow and uniform batch temperature.
The ROSS Model CDA-25 (pictured) includes dry-running Double FlexiLip seals on both agitator shafts, making it appropriate for vacuum operations up to 29.5” Hg. This model also features a portable mixing vessel with heating/cooling jacket.
Articles in this issue
about 5 years ago
Putting the Patient at the Heart of Dosage Form Designabout 5 years ago
A Digital Supply Chain Helps Ensure API Qualityabout 5 years ago
Serialization: Reducing Counterfeit Drugs and Increasing Salesabout 5 years ago
Designing Incubators for Cell Therapy Manufacturingabout 5 years ago
Implementing Data Integrity Compliance in a GLP Test Facilityabout 5 years ago
Developing the Best Formulation Partnershipabout 5 years ago
Working Towards Zero Emissionsabout 5 years ago
FDA Prioritizes Vaccine Review and Process ImprovementsRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech’s Weekly Roundup—September 25, 2026
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5